Nephrocare Health Services
BSE: NEPHROPLUS · Healthcare Service Provider
Snapshot
Unlock Nephrocare Health Services's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nephrocare Health Services Limited is India's largest dialysis-care provider, offering a comprehensive range of renal-care services including haemodialysis, peritoneal dialysis, and home-based care. The company operates through a diverse network of hospital-based clinics, standalone centres, and Public-Private Partnership (PPP) units.
Business Model
The company generates revenue by providing end-to-end dialysis services and renal-care support across various clinical settings. Its model integrates pharmacy support, diagnostics, and wellness management into its core dialysis service offerings.
Growth Outlook
Growth is driven by the expansion of its clinic network and the scaling of its diverse service portfolio, including dialysis-on-wheels and home haemodialysis. The company continues to leverage PPP models to increase its footprint across India and international markets.
Key Risks
- Regulatory and Compliance Risk. The company is subject to stringent healthcare regulations and quality standards, where non-compliance could lead to operational disruptions or loss of licenses.
- Dependency on PPP Contracts. A significant portion of the business relies on Public-Private Partnership agreements, which are subject to government policy changes and contract renewal risks.
- Operational Cost Inflation. Rising costs for medical consumables, specialised equipment, and skilled nephrology staff may exert pressure on profit margins.
- Competitive Intensity. The dialysis sector is highly competitive, with potential threats from both large hospital chains and specialised regional players.
Start your research today
Unlock AI insights, financials, peers and live data on Nephrocare Health Services and 5,000+ companies — free.
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Nephrocare Health ServicesNEPHROPLUS | ₹6,994 Cr | — | — | — | 23.0% | — | — | — |
Metropolis Healthcare Ltd.METROPOLIS | ₹12,205 Cr | 25.21 | 27.32 | 21.8% | 26.0% | 14.3% | 17.8% | -73.7% |
Thyrocare Technologies Ltd.THYROCARE | ₹9,170 Cr | 33.71 | 30.64 | 21.1% | 34.0% | 31.1% | 38.4% | -57.0% |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,817 Cr | 18.63 | 8.75 | 10.2% | 32.5% | 10.5% | 13.3% | -32.6% |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,731 Cr | 47.49 | 16.34 | 22.5% | 32.7% | 15.8% | 18.6% | +9.8% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,253 Cr | 20.88 | 14.79 | 41.9% | 58.0% | 21.2% | 26.3% | +1.9% |
As of Mar 2026
Financials
Nephrocare Health Services
BSE: NEPHROPLUS · Healthcare Service Provider
Snapshot
Unlock Nephrocare Health Services's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Nephrocare Health Services Limited is India's largest dialysis-care provider, offering a comprehensive range of renal-care services including haemodialysis, peritoneal dialysis, and home-based care. The company operates through a diverse network of hospital-based clinics, standalone centres, and Public-Private Partnership (PPP) units.
Business Model
The company generates revenue by providing end-to-end dialysis services and renal-care support across various clinical settings. Its model integrates pharmacy support, diagnostics, and wellness management into its core dialysis service offerings.
Growth Outlook
Growth is driven by the expansion of its clinic network and the scaling of its diverse service portfolio, including dialysis-on-wheels and home haemodialysis. The company continues to leverage PPP models to increase its footprint across India and international markets.
Key Risks
- Regulatory and Compliance Risk. The company is subject to stringent healthcare regulations and quality standards, where non-compliance could lead to operational disruptions or loss of licenses.
- Dependency on PPP Contracts. A significant portion of the business relies on Public-Private Partnership agreements, which are subject to government policy changes and contract renewal risks.
- Operational Cost Inflation. Rising costs for medical consumables, specialised equipment, and skilled nephrology staff may exert pressure on profit margins.
- Competitive Intensity. The dialysis sector is highly competitive, with potential threats from both large hospital chains and specialised regional players.
Start your research today
Unlock AI insights, financials, peers and live data on Nephrocare Health Services and 5,000+ companies — free.
Peers · Healthcare Service Provider
As of Mar 2026